Access to medicines: MSF demands review of USTR Special 301 report on trade barriers
February 7, 2020In a letter to the United States Trade Representative (USTR) on 6th February 2020, Médecins Sans Frontières (MSF)/Doctors Without Borders submitted comments to the review process of USTR’s 2020 Special 301 Report and raised concerns of the public health impact of...
Read more
MSF: Global vaccines community must urgently support roll out of new more affordable pneumonia vaccine
January 29, 2020Global vaccines community must do everything it can to help introduce the new, more affordable pneumonia vaccine in all countries, especially middle-income countries Barcelona – As governments and the global vaccines community gather this week at the first ever Global...
Read more
Access to medicines: As J&J release earnings, MSF protests price of lifesaving TB drug
January 23, 2020As J&J release earnings, MSF protests price of lifesaving TB drug in front of New York Stock Exchange New York, 22 January 2020—Médecins Sans Frontières (MSF) protested in front of the New York Stock Exchange in New York today, demanding...
Read more
Access to medicines: Gavi must ensure more children get new, more affordable pneumonia vaccine
January 21, 2020Geneva, 21 January 2020 — As Gavi, the Vaccine Alliance, starts to commemorate its 20th year and launches a new fundraising appeal, the international medical humanitarian organisation Doctors Without Borders/Médecins Sans Frontières (MSF) stressed that more must be done to...
Read more
MSF: $262 million subsidy should not go to pharma giants Pfizer and GSK for pneumonia vaccine
December 4, 2019New Delhi - Ahead of this week’s board meeting of Gavi, the Vaccine Alliance, in New Delhi, India, Doctors without Borders/Médecins Sans Frontières (MSF) called on board members to immediately stop paying out funds from a remaining US$262 million subsidy...
Read more
MSF and TB activists disrupt opening of TB conference to protest drug corporations keeping life-saving medicines from people
October 30, 2019Newer medicines for DR-TB are desperately needed, but barriers to access, including high prices, keep them out of reach for most people around the world. Hyderabad, 30 October – Doctors Without Borders/Médecins Sans Frontières (MSF) joined tuberculosis (TB) activists to disrupt...
Read more
MSF urges PM Modi not to make any trade commitments to US threatening access to medicines
September 20, 2019Ahead of the Prime Minister Narendra Modi’s visit to the US to discuss a ‘trade-package’ with the US President Donald Trump, Médecins Sans Frontières/ Doctors Without Borders (MSF) urges the Indian government to not make any commitments regarding intellectual property,...
Read more
Gilead Sciences fails on promise to expand access to lifesaving drug for people living with HIV
June 27, 2019Inaction by US pharmaceutical corporation Gilead to follow through on its so-called ‘access initiative’ leaves people unable to access a vital drug to treat a deadly infection. Delhi/Geneva - Pharmaceutical corporation Gilead Sciences has failed to deliver on promises to make...
Read more
MSF: U.S. Special 301 report undermines efforts to lower medicine prices globally
April 26, 2019On the eve of World Intellectual Property Day, the United States Trade Representative released its annual “Special 301 Report.” Developing countries like India and Malaysia once again face unfair pressure from the US government over the measures these countries have...
Read more
Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India
February 14, 2019Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline. Nandita...
Read more
Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India
February 8, 2019Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline....
Read more
Access to medicines
February 6, 2019Unaffordable, unavailable, not adapted - people around the world face these challenges in accessing lifesaving medicines. During the 1990s, MSF teams made a bitter observation: we were failing to treat some of our patients suffering from infectious diseases, while in...
Read more
